Clinical trial
CHAPAS-5: An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa
NCT07792096 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHAPAS-5: An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa
- Lead sponsor
- University College, London
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection